CYP24A1 and chronic kidney disease: Impaired vascular production of active vitamin D and its increased degradation by 24-OHase may exacerbate circulating 1,25-OH-D deficiency observed in CKD patients in the context of 25-OH-D deficiency, which has been shown to be closely associated with cardiovascular morbidity and mortality [31].